Your browser doesn't support javascript.
loading
Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry.
Hartkopf, Andreas D; Huober, Jens; Volz, Bernhard; Nabieva, Naiba; Taran, Florin-Andrei; Schwitulla, Judith; Overkamp, Friedrich; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Häberle, Lothar; Ettl, Johannes; Lux, Michael P; Lüftner, Diana; Wallwiener, Markus; Müller, Volkmar; Beckmann, Matthias W; Belleville, Erik; Wimberger, Pauline; Hielscher, Carsten; Geberth, Matthias; Fersis, Nikos; Abenhardt, Wolfgang; Kurbacher, Christian; Wuerstlein, Rachel; Thomssen, Christoph; Untch, Michael; Fasching, Peter A; Janni, Wolfgang; Fehm, Tanja N; Wallwiener, Diethelm; Brucker, Sara Y; Schneeweiss, Andreas.
Affiliation
  • Hartkopf AD; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen, Germany.
  • Huober J; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.
  • Volz B; Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Germany.
  • Nabieva N; Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Germany.
  • Taran FA; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen, Germany.
  • Schwitulla J; Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Germany.
  • Overkamp F; Oncologianova GmbH, Recklinghausen, Germany.
  • Kolberg HC; Marienhospital Bottrop, Bottrop, Germany.
  • Hadji P; Department of Bone Oncology, Nordwest Hospital, Frankfurt, Germany.
  • Tesch H; Oncology Practice at Bethanien Hospital Frankfurt, Germany.
  • Häberle L; Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Germany; Biostatistics Unit, University Hospital Erlangen, Department of Gynecology and Obstetrics, Germany.
  • Ettl J; Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Lux MP; Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Germany.
  • Lüftner D; Charité University Hospital, Campus Benjamin Franklin, Department of Hematology, Oncology and Tumour Immunology, Berlin, Germany.
  • Wallwiener M; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Müller V; Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.
  • Beckmann MW; Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Germany.
  • Belleville E; ClinSol GmbH & Co KG, Würzburg, Germany.
  • Wimberger P; Department of Gynecology and Obstetrics, Technische Universität Dresden, Dresden, Germany.
  • Hielscher C; gSUND Gynäkologie Kompetenzzentrum Stralsund, Stralsund, Germany.
  • Geberth M; Gynäkoonkologie Gemeinschaftspraxis, Praxisklinik am Rosengarten, Mannheim, Germany.
  • Fersis N; Department of Gynecology and Obstetrics, Klinik Hohe Warte, Bayreuth, Germany.
  • Abenhardt W; MVZ Onkologie, Onkologie im Elisenhof, München, Germany.
  • Kurbacher C; Department of Gynecology and Obstetrics, Medizinisches Zentrum Bonn Friedensplatz, Bonn, Germany.
  • Wuerstlein R; Department of Gynecology and Obstetrics, Breast Center and CCC Munich, University Hospital Munich, Germany.
  • Thomssen C; Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Untch M; Department of Gynecology and Obstetrics, Helios Clinics Berlin Buch, Berlin, Germany.
  • Fasching PA; Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Germany. Electronic address: peter.fasching@uk-erlangen.de.
  • Janni W; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.
  • Fehm TN; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Germany.
  • Wallwiener D; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen, Germany.
  • Brucker SY; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen, Germany.
  • Schneeweiss A; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases and Department of Gynecology and Obstetrics, Heidelberg University Hospital, Heidelberg, Germany.
Breast ; 37: 42-51, 2018 Feb.
Article de En | MEDLINE | ID: mdl-29100043
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Protocoles de polychimiothérapie antinéoplasique Limites: Aged / Female / Humans / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Breast Sujet du journal: ENDOCRINOLOGIA / NEOPLASIAS Année: 2018 Type de document: Article Pays d'affiliation: Allemagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Protocoles de polychimiothérapie antinéoplasique Limites: Aged / Female / Humans / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Breast Sujet du journal: ENDOCRINOLOGIA / NEOPLASIAS Année: 2018 Type de document: Article Pays d'affiliation: Allemagne